GENEDX HOLDINGS CORP (WGS)
US81663L2007 - Common Stock
Taking everything into account, WGS scores 3 out of 10 in our fundamental rating. WGS was compared to 114 industry peers in the Health Care Providers & Services industry. While WGS seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, WGS is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
WGS had negative earnings in the past year.
WGS had a negative operating cash flow in the past year.
In the past 5 years WGS always reported negative net income.
In the past 5 years WGS always reported negative operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -34.22%, WGS is doing worse than 82.30% of the companies in the same industry.
WGS has a Return On Equity of -65.16%. This is in the lower half of the industry: WGS underperforms 71.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -34.22% | ||
| ROE | -65.16% | ||
| ROIC | N/A |
ROA(3y)-66.03%
ROA(5y)-62.01%
ROE(3y)-118.9%
ROE(5y)-1173.25%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Gross Margin value of 50.57%, WGS belongs to the best of the industry, outperforming 81.42% of the companies in the same industry.
WGS's Gross Margin has improved in the last couple of years.
WGS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 50.57% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y7.53%
2. Health
2.1 Basic Checks
WGS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, WGS has more shares outstanding
The debt/assets ratio for WGS is higher compared to a year ago.
2.2 Solvency
WGS has an Altman-Z score of -2.42. This is a bad value and indicates that WGS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of WGS (-2.42) is worse than 83.19% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that WGS is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.25, WGS is in the better half of the industry, outperforming 69.03% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.42 |
ROIC/WACCN/A
WACC8.6%
2.3 Liquidity
A Current Ratio of 3.22 indicates that WGS has no problem at all paying its short term obligations.
WGS's Current ratio of 3.22 is amongst the best of the industry. WGS outperforms 88.50% of its industry peers.
A Quick Ratio of 2.99 indicates that WGS has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.99, WGS belongs to the top of the industry, outperforming 87.61% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.22 | ||
| Quick Ratio | 2.99 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 86.37% over the past year.
Looking at the last year, WGS shows a decrease in Revenue. The Revenue has decreased by -0.91% in the last year.
The Revenue has been growing by 8.73% on average over the past years. This is quite good.
EPS 1Y (TTM)86.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.48%
Revenue 1Y (TTM)-0.91%
Revenue growth 3Y4.15%
Revenue growth 5Y8.73%
Sales Q2Q%41.64%
3.2 Future
The Earnings Per Share is expected to grow by 28.58% on average over the next years. This is a very strong growth
WGS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.88% yearly.
EPS Next Y80.37%
EPS Next 2Y40.91%
EPS Next 3Y28.58%
EPS Next 5YN/A
Revenue Next Year24.44%
Revenue Next 2Y19.13%
Revenue Next 3Y18.88%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for WGS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for WGS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as WGS's earnings are expected to grow with 28.58% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.91%
EPS Next 3Y28.58%
5. Dividend
5.1 Amount
WGS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
GENEDX HOLDINGS CORP
NASDAQ:WGS (6/14/2024, 7:00:02 PM)
After market: 28.78 0 (0%)28.78
+0.01 (+0.03%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap752.60M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -34.22% | ||
| ROE | -65.16% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 50.57% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.22 | ||
| Quick Ratio | 2.99 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)86.37%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y80.37%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-0.91%
Revenue growth 3Y4.15%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y